DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
51. 全身性強皮症
Scleroderma
Clinical trials
/
Disease details
臨床試験数
:
525
/
薬物数
:
565
- (
DrugBank
:
148
) /
標的遺伝子数
:
114
-
標的パスウェイ数
:
217
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT00241189
(
ClinicalTrials.gov
)
August 2002
14/10/2005
Rapamycin
vs Methotrexate in Diffuse SSc
A 48-week, Double-blind, Randomized, Parallel Phase I/II Study of Oral
Rapamycin
Versus Methotrexate in Systemic Sclerosis (Scleroderma)
A 48-week, Double-blind, Randomized, Parallel Phase I/II Study of Oral
Rapamycin
Versus Methotrexate ...
Systemic Sclerosis
Drug:
rapamycin
;Drug:
methotrexate
University of California, Los Angeles
NULL
Completed
18 Years
70 Years
Both
17
Phase 1/Phase 2
United States